CA2213621A1 - Associations antivirales de bch-189 et de ritonavir - Google Patents

Associations antivirales de bch-189 et de ritonavir

Info

Publication number
CA2213621A1
CA2213621A1 CA002213621A CA2213621A CA2213621A1 CA 2213621 A1 CA2213621 A1 CA 2213621A1 CA 002213621 A CA002213621 A CA 002213621A CA 2213621 A CA2213621 A CA 2213621A CA 2213621 A1 CA2213621 A1 CA 2213621A1
Authority
CA
Canada
Prior art keywords
compound
ritonavir
formula
combination
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002213621A
Other languages
English (en)
Inventor
Hugh Brownlie Mcdade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2213621A1 publication Critical patent/CA2213621A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des associations comprenant un composé de la formule (I), ou un dérivé pharmaceutiquement acceptable de ce composé, et du ritonavir ou un dérivé pharmaceutiquement acceptable de ce dernier; ainsi que des formulations pharmaceutiques les contenant et leur utilisation pour le traitement d'infections virales.
CA002213621A 1995-02-25 1996-02-22 Associations antivirales de bch-189 et de ritonavir Abandoned CA2213621A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9503850.1 1995-02-25
GBGB9503850.1A GB9503850D0 (en) 1995-02-25 1995-02-25 Medicaments

Publications (1)

Publication Number Publication Date
CA2213621A1 true CA2213621A1 (fr) 1996-09-06

Family

ID=10770279

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002213621A Abandoned CA2213621A1 (fr) 1995-02-25 1996-02-22 Associations antivirales de bch-189 et de ritonavir

Country Status (6)

Country Link
EP (1) EP0810873A1 (fr)
JP (1) JPH11501303A (fr)
AU (1) AU4879496A (fr)
CA (1) CA2213621A1 (fr)
GB (1) GB9503850D0 (fr)
WO (1) WO1996026734A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049411A1 (fr) 1996-06-25 1997-12-31 Glaxo Group Limited Combinaisons comprenant du vx478, de la zidovudine, du ftc et/ou 3tc pouvant etre utilisees dans le traitement du vih
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
FR2779653B1 (fr) * 1998-06-11 2002-12-20 Inst Nat Sante Rech Med Utilisation de composes modulateurs du proteasome en therapie
FR2878747B1 (fr) * 2004-12-03 2007-03-30 Pierre Fabre Medicament Sa Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010496A1 (fr) * 1990-12-05 1992-06-25 University Of Georgia Research Foundation, Inc. NUCLEOSIDES DE β-L-(-)-1,3-OXATHIOLANE ENANTIOMERIQUEMENT PURS
WO1992020344A1 (fr) * 1991-05-16 1992-11-26 Glaxo Group Limited Combinaisons antivirales contenant des analogues de nucleosides
ES2138624T3 (es) * 1992-05-13 2000-01-16 Wellcome Found Combinaciones terapeuticas.
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій

Also Published As

Publication number Publication date
AU4879496A (en) 1996-09-18
JPH11501303A (ja) 1999-02-02
WO1996026734A1 (fr) 1996-09-06
GB9503850D0 (en) 1995-04-19
EP0810873A1 (fr) 1997-12-10

Similar Documents

Publication Publication Date Title
US5627186A (en) Antiviral combinations
AU715213B2 (en) Synergistic combinations of zidovudine, 1592U89 and 3TC or FTC
EP0844878A1 (fr) Analogues de nucleosides 1,3-oxathiolane utilises dans le traitement de l'hepatite c
JP2818299B2 (ja) ウイルス感染の治療におけるジデオキシヌクレオシドアナローグの使用
AU727983B2 (en) Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatment of HIV
SK99899A3 (en) Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids
CA2213621A1 (fr) Associations antivirales de bch-189 et de ritonavir
US5612333A (en) Antiviral combinations
RU2139059C1 (ru) Противовирусная комбинация, содержащая нуклеозидный аналог, фармацевтическая композиция, способ лечения
AU4568893A (en) Antiviral combinations
WO2004002498A1 (fr) Regimes antiviraux
AU702469B2 (en) Composition and method of treating retroviral infection
IT202100024668A1 (it) Composizioni e metodi per la terapia antivirale combinata
EP4337323A1 (fr) Composés hétérocycliques bicycliques pour la prophylaxie et le traitement d'infections virales
WO2023244968A1 (fr) Méthodes de traitement de troubles auto-immuns avec des inhibiteurs d'histone désacétylase
MXPA99008690A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FZDE Dead